Treatment Approaches for Patients with EGFR Exon 20–Mutated NSCLC

 

Insights from 2023 ESMO Annual Meeting
P

ESMO 2023 Summary: "Recent Developments in the Treatment of Patients With EGFR ex 20 Ins NSCLC"

By Insights from 2023 ESMO Annual Meeting FEATURING Paul Mitchell
By Insights from 2023 ESMO Annual Meeting FEATURING Paul Mitchell
297 views
November 10, 2023
0 Comments
Login to view comments. Click here to Login
Treatment Approaches for Patients with EGFR Exon 20–Mutated NSCLC
35:40
Balazs Halmos

Year in Review: Lung Cancer

14:59
University of Colorado Cancer Center

EGFR Exon 20 Insertion Mutations in NSCLC: Optimal and “Soon to Be O…

Feat. T. Patil
08:30
Insights from 2023 ESMO Annual Meeting

PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EG…

Feat. N. Girard
05:32
Insights from 2023 WCLC

Molecular and Clinical Characterization of NSCLC With MET Fusions

Feat. C. Kim
15:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Recent Developments in the Treatment of Pat…

Feat. P. Mitchell
19:02
ecancer

ESMO 2023 Insights: "Latest in EGFR Ex20ins Advanced NSCLC"

Feat. A. Spira, J. Sabari, E. Felip
04:27
ecancer

ELCC 2023 on Long-Term Efficacy, Safety & Predictors of Response…

Feat. N. Girard